Signaling control of the constitutive androstane receptor (CAR)

Abstract

The constitutive androstane receptor (CAR, NR1I3) plays a crucial role in the regulation of drug metabolism, energy homeostasis, and cancer development through modulating the transcription of its numerous target genes. Different from prototypical nuclear receptors, CAR can be activated by either direct ligand binding or ligand-independent (indirect) mechanisms both initiated with nuclear translocation of CAR from the cytoplasm. In comparison to the well-defined ligand-based activation, indirect activation of CAR appears to be exclusively involved in the nuclear translocation through mechanisms yet to be fully understood. Accumulating evidence reveals that without activation, CAR forms a protein complex in the cytoplasm where it can be functionally affected by multiple signaling pathways. In this review, we discuss recent progresses in our understanding of the signaling regulation of CAR nuclear accumulation and activation. We expect that this review will also provide greater insight into the similarity and difference between the mechanisms of direct vs. indirect human CAR activation.

Keywords

constitutive androstane receptor / nuclear translocation / phosphorylation / signaling regulation

References

[1] BauerD, WolframN, KahlGF, Hirsch-ErnstKI (2004) Transcriptional regulation of CYP2B1 induction in primary rat hepatocyte cultures: repression by epidermal growth factor is mediated via a distal enhancer region. Mol Pharmacol65: 172-180

[2] BuckleyDB, KlaassenCD (2009) Induction of mouse UDPglucuronosyltransferase mRNA expression in liver and intestine by activators of aryl-hydrocarbon receptor, constitutive androstane receptor, pregnane X receptor, peroxisome proliferatoractivated receptor alpha, and nuclear factor erythroid 2-related factor 2. Drug Metab Dispos37: 847-856

[3] BurkO, ArnoldKA, GeickA, TegudeH, EichelbaumM (2005a) A role for constitutive androstane receptor in the regulation of human intestinal MDR1 expression. Biol Chem386: 503-513

[4] BurkO, ArnoldKA, NusslerAK, SchaeffelerE, EfimovaE, AveryBA, AveryMA, FrommMF, EichelbaumM (2005b) Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor. Mol Pharmacol67: 1954-1965

[5] CervenyL, SvecovaL, AnzenbacherovaE, VrzalR, StaudF, DvorakZ, UlrichovaJ, AnzenbacherP, PavekP (2007) Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways. Drug Metab Dispos35: 1032-1041

[6] ChakrabortyS, KanakasabaiS, BrightJJ (2011) Constitutive androstane receptor agonist CITCO inhibits growth and expansion of brain tumour stem cells. Br J Cancer104: 448-459

[7] ChangTK, BandieraSM, ChenJ (2003) Constitutive androstane receptor and pregnane X receptor gene expression in human liver: interindividual variability and correlation with CYP2B6 mRNA levels. Drug Metab Dispos31: 7-10

[8] CherringtonNJ, HartleyDP, LiN, JohnsonDR, KlaassenCD (2002) Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats. J Pharmacol Exp Ther300: 97-104

[9] CherringtonNJ, SlittAL, MaherJM, ZhangXX, ZhangJ, HuangW, WanYJ, MooreDD, KlaassenCD (2003) Induction of multidrug resistance protein 3 (mrp3) in vivo is independent of constitutive androstane receptor. Drug Metab Dispos31: 1315-1319

[10] ColumbanoA, Ledda-ColumbanoGM, PibiriM, CossuC, MenegazziM, MooreDD, HuangW, TianJ, LockerJ (2005) Gadd45beta is induced through a CAR-dependent, TNF-independent pathway in murine liver hyperplasia. Hepatology42: 1118-1126

[11] Di FiorePP, SegattoO, TaylorWG, AaronsonSA, PierceJH (1990) EGF receptor and erbB-2 tyrosine kinase domains confer cell specificity for mitogenic signaling. Science248: 79-83

[12] DingX, LichtiK, KimI, GonzalezFJ, StaudingerJL (2006) Regulation of constitutive androstane receptor and its target genes by fasting, cAMP, hepatocyte nuclear factor alpha, and the coactivator peroxisome proliferator-activated receptor gamma coactivator-1 alpha. J Biol Chem281: 26540-26551

[13] DongB, SahaPK, HuangW, ChenW, Abu-ElheigaLA, WakilSJ, StevensRD, IlkayevaO, NewgardCB, ChanL (2009) Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease. Proc Natl Acad Sci USA106: 18831-18836

[14] DuJ, ChenQ, TakemoriH, XuH (2008) SIK2 can be activated by deprivation of nutrition and it inhibits expression of lipogenic genes in adipocytes. Obesity (Silver Spring)16: 531-538

[15] FaucetteSR, SueyoshiT, SmithCM, NegishiM, LecluyseEL, WangH (2006) Differential regulation of hepatic CYP2B6 and CYP3A4 genes by constitutive androstane receptor but not pregnane X receptor. J Pharmacol Exp Ther317: 1200-1209

[16] FergusonSS, LeCluyseEL, NegishiM, GoldsteinJA (2002) Regulation of human CYP2C9 by the constitutive androstane receptor: discovery of a new distal binding site. Mol Pharmacol62: 737-746

[17] FergusonSS, ChenY, LeCluyseEL, NegishiM, GoldsteinJA (2005) Human CYP2C8 is transcriptionally regulated by the nuclear receptors constitutive androstane receptor, pregnane X receptor, glucocorticoid receptor, and hepatic nuclear factor 4 alpha. Mol Pharmacol68: 747-757

[18] FormanBM, TzameliI, ChoiHS, ChenJ, SimhaD, SeolW, EvansRM, MooreDD (1998) Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta. Nature395: 612-615

[19] GaoJ, HeJ, ZhaiY, WadaT, XieW (2009) The constitutive androstane receptor is an anti-obesity nuclear receptor that improves insulin sensitivity. J Biol Chem284: 25984-25992

[20] Gerbal-ChaloinS, DaujatM, PascussiJM, Pichard-GarciaL, VilaremMJ, MaurelP (2002) Transcriptional regulation of CYP2C9 gene. Role of glucocorticoid receptor and constitutive androstane receptor. J Biol Chem277: 209-217

[21] GiguereV (1999) Orphan nuclear receptors: from gene to function. Endocr Rev20: 689-725

[22] GoodwinB, HodgsonE, D’CostaDJ, RobertsonGR, LiddleC (2002) Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptor. Mol Pharmacol62: 359-365

[23] HandschinC, MeyerUA (2003) Induction of drug metabolism: the role of nuclear receptors. Pharmacol Rev55: 649-673

[24] HardieDG, RossFA, HawleySA (2012) AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Bio13: 251-262

[25] HeL, SabetA, DjedjosS, MillerR, SunX, HussainMA, RadovickS, WondisfordFE (2009) Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein. Cell137: 635-646

[26] HonkakoskiP, ZelkoI, SueyoshiT, NegishiM (1998) The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Mol Cell Biol18: 5652-5658

[27] HuangW, ZhangJ, WashingtonM, LiuJ, ParantJM, LozanoG, MooreDD (2005) Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor. Mol Endocrinol19: 1646-1653

[28] InokiK, KimJ, GuanKL (2012) AMPK and mTOR in cellular energy homeostasis and drug targets. Annu Rev Pharmacol52: 381-400

[29] JoannardF, RisselM, GilotD, AndersonA, Orfila-LefeuvreL, GuillouzoA, AtfiA, Lagadic-GossmannD (2006) Role for mitogen-activated protein kinases in phenobarbital-induced expression of cytochrome P4502B in primary cultures of rat hepatocytes. Toxicol Lett161: 61-72

[30] JohanssonI, Ingelman-SundbergM (2010) Genetic polymorphism and toxicology-withemphasis on cytochromep 450. Toxicol Sci120: 1-13

[31] KachayloEM, YarushkinAA, PustylnyakVO (2012) Constitutive androstane receptor activation by 2,4,6-triphenyldioxane-1,3 suppresses the expression of the gluconeogenic genes. Eur J Pharmacol679: 139-143

[32] KaminoH, MooreR, NegishiM (2011a) Role of a novel CARinduced gene, TUBA8, in hepatocellular carcinoma cell lines. Cancer Genet204: 382-391

[33] KaminoH, YamazakiY, SaitoK, TakizawaD, KakizakiS, MooreR, NegishiM (2011b) Nuclear receptor CAR-regulated expression of the FAM84A gene during the development of mouse liver tumors. Int J Oncol38: 1511-1520

[34] KannoY, InoueY, InouyeY (2010) 5-aminoimidazole-4-carboxamide-1-beta-ribofuranoside (AICAR) prevents nuclear translocation of constitutive androstane receptor by AMP-activated protein kinase (AMPK) independent manner. J Toxicol Sci35: 571-576

[35] KawamotoT, SueyoshiT, ZelkoI, MooreR, WashburnK, NegishiM (1999) Phenobarbital-responsive nuclear translocation of the receptorCAR in induction of the CYP2B gene. MolCellBiol19: 6318-6322

[36] KietzmannT, Hirsch-ErnstKI, KahlGF, JungermannK (1999) Mimicry in primary rat hepatocyte cultures of the in vivo perivenous induction by phenobarbital of cytochrome P-450 2B1 mRNA: role of epidermal growth factor and perivenous oxygen tension. Mol Pharmacol56: 46-53

[37] KobayashiK, SueyoshiT, InoueK, MooreR, NegishiM (2003) Cytoplasmic accumulation of the nuclear receptor CAR by a tetratricopeptide repeat protein in HepG2 cells. Mol Pharmacol64: 1069-1075

[38] KoikeC, MooreR, NegishiM (2007) Extracellular signal-regulated kinase is an endogenous signal retaining the nuclear constitutive active/androstane receptor (CAR) in the cytoplasm of mouse primary hepatocytes. Mol Pharmacol71: 1217-1221

[39] LiH, WangH (2010) Activation of xenobiotic receptors: driving into the nucleus. Expert Opin Drug Metab Toxicol6: 409-426

[40] LiL, ChenT, StantonJD, SueyoshiT, NegishiM, WangH (2008) The peripheral benzodiazepine receptor ligand 1-(2-chlorophenyl-methylpropyl)-3-isoquinoline-carboxamide is a novel antagonist of human constitutive androstane receptor. Mol Pharmacol74: 443-453

[41] LiH, ChenT, CottrellJ, WangH (2009) Nuclear translocation of adenoviral-enhanced yellow fluorescent protein-tagged-human constitutive androstane receptor (hCAR): a novel tool for screening hCAR activators in human primary hepatocytes. Drug Metab Dispos37: 1098-1106

[42] LiL, SinzMW, ZimmermannK, WangH (2012) An insulin-like growth factor 1 receptor inhibitor induces CYP3A4 expression through a pregnane X receptor-independent, noncanonical constitutive androstane receptor-related mechanism. J Pharmacol Exp Ther340: 688-697

[43] MaglichJM, StoltzCM, GoodwinB, Hawkins-BrownD, MooreJT, KliewerSA (2002) Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol Pharmacol62: 638-646

[44] MaglichJM, ParksDJ, MooreLB, CollinsJL, GoodwinB, BillinAN, StoltzCA, KliewerSA, LambertMH, WillsonTM (2003) Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. J Biol Chem278: 17277-17283

[45] MaglichJM, WatsonJ, McMillenPJ, GoodwinB, WillsonTM, MooreJT (2004) The nuclear receptor CAR is a regulator of thyroid hormone metabolism during caloric restriction. J Biol Chem279: 19832-19838

[46] MakinenJ, FrankC, JyrkkarinneJ, GyntherJ, CarlbergC, HonkakoskiP (2002) Modulation of mouse and human phenobarbital-responsive enhancer module by nuclear receptors. Mol Pharmacol62: 366-378

[47] MasuyamaH, HiramatsuY (2012) Treatment with a constitutive androstane receptor ligand ameliorates the signs of preeclampsia in high-fat diet-induced obese pregnant mice. Mol Cell Endocrinol348: 120-127

[48] MolnarF, KublbeckJ, JyrkkarinneJ, PrantnerV, HonkakoskiP (2013) An update on the constitutive androstane receptor (CAR). Drug Metabol Drug Interact28: 79-93

[49] MooreLB, ParksDJ, JonesSA, BledsoeRK, ConslerTG, StimmelJB, GoodwinB, LiddleC, BlanchardSG, WillsonTM (2000) Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem275: 15122-15127

[50] MutohS, OsabeM, InoueK, MooreR, PedersenL, PereraL, RebollosoY, SueyoshiT, NegishiM (2009) Dephosphorylation of threonine 38 is required for nuclear translocation and activation of human xenobiotic receptor CAR (NR1I3). J Biol Chem284: 34785-34792

[51] MutohS, SobhanyM, MooreR, PereraL, PedersenL, SueyoshiT, NegishiM (2013) Phenobarbital indirectly activates the constitutive active androstane receptor (CAR) by inhibition of epidermal growth factor receptor signaling. Sci Signal6: ra31

[52] NakajimaY, TakagiH, KakizakiS, HoriguchiN, SatoK, SunagaN, MoriM (2012) Gefitinib and gemcitabine coordinately inhibited the proliferation of cholangiocarcinoma cells. Anticancer Res32: 5251-5262

[53] NumazawaS, ShindoS, MaruyamaK, ChibanaF, KawaharaY, AshinoT, TanakaS, YoshidaT (2005) Impaired nuclear translocation ofCAR in hepatic preneoplastic lesions: association with an attenuated CYP2B induction by phenobarbital. FEBS Lett579: 3560-3564

[54] OsabeM, NegishiM (2011) Active ERK1/2 protein interacts with the phosphorylated nuclear constitutive active/androstane receptor (CAR; NR1I3), repressing dephosphorylation and sequestering CAR in the cytoplasm. J Biol Chem286: 35763-35769

[55] OsabeM, SugataniJ, FukuyamaT, IkushiroS, IkariA, MiwaM (2008) Expression of hepatic UDP-glucuronosyltransferase 1A1 and 1A6 correlated with increased expression of the nuclear constitutive androstane receptor and peroxisome proliferatoractivated receptor alpha in male rats fed a high-fat and highsucrose diet. Drug Metab Dispos36: 294-302

[56] OsabeM, SugataniJ, TakemuraA, KurosawaM, YamazakiY, IkariA, MiwaM (2009) Up-regulation of CAR expression through Elk-1 in HepG2 and SW480 cells by serum starvation stress. FEBS Lett583: 885-889

[57] PascussiJM, Gerbal-ChaloinS, FabreJM, MaurelP, VilaremMJ (2000) Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: consequences on cytochrome P450 gene regulation. Mol Pharmacol F58: 1441-1450

[58] PascussiJM, Busson-Le ConiatM, MaurelP, VilaremMJ (2003) Transcriptional analysis of the orphan nuclear receptor constitutive androstane receptor (NR1I3) gene promoter: identification of a distal glucocorticoid response element. Mol Endocrinol17: 42-55

[59] PlantN (2007) The human cytochrome P450 sub-family: transcriptional regulation, inter-individual variation and interaction networks. Biochim Biophys Acta1770: 478-488

[60] QatananiM, MooreDD (2005) CAR, the continuously advancing receptor, in drug metabolism and disease. Curr Drug Metab6: 329-339

[61] QatananiM, ZhangJ, MooreDD (2005) Role of the constitutive androstane receptor in xenobiotic-induced thyroid hormone metabolism. Endocrinology146: 995-1002

[62] RencurelF, StenhouseA, HawleySA, FriedbergT, HardieDG, SutherlandC, WolfCR (2005) AMP-activated protein kinase mediates phenobarbital induction of CYP2B gene expression in hepatocytes and a newly derived human hepatoma cell line. J Biol Chem280: 4367-4373

[63] RencurelF, ForetzM, KaufmannMR, StrokaD, LooserR, LeclercI, da Silva XavierG, RutterGA, ViolletB, MeyerUA (2006) Stimulation of AMP-activated protein kinase is essential for the induction of drug metabolizing enzymes by phenobarbital in human and mouse liver. Mol Pharmacol70: 1925-1934

[64] RossJ, PlummerSM, RodeA, ScheerN, BowerCC, VogelO, HendersonCJ, WolfCR, ElcombeCR (2010) Human constitutive androstane receptor (CAR) and pregnane X receptor (PXR) support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogens phenobarbital and chlordane in vivo. Toxicol Sci116: 452-466

[65] RothA, LooserR, KaufmannM, BlattlerSM, RencurelF, HuangW, MooreDD, MeyerUA (2008) Regulatory cross-talk between drug metabolism and lipid homeostasis: constitutive androstane receptor and pregnane X receptor increase Insig-1 expression. Mol Pharmacol73: 1282-1289

[66] SaitoK, KobayashiK, MizunoY, FukuchiY, FurihataT, ChibaK (2010) Peroxisome proliferator-activated receptor alpha (PPARalpha) agonists induce constitutive androstane receptor (CAR) and cytochrome P450 2B in rat primary hepatocytes. Drug Metab Pharmacokinet25: 108-111

[67] SaitoK, MooreR, NegishiM (2013) p38 mitogen-activated protein kinase regulates nuclear receptor CAR that activates the CYP2B6 gene. Drug Metab Dispos41: 1170-1173

[68] ShanL, VincentJ, BrunzelleJS, DussaultI, LinM, IanculescuI, ShermanMA, FormanBM, FernandezEJ (2004) Structure of the murine constitutive androstane receptor complexed to androstenol: a molecular basis for inverse agonism. Mol Cell16: 907-917

[69] ShinDM, ZhangH, SabaNF, ChenAY, NannapaneniS, AminAR, MullerS, LewisM, SicaG, KonoS (2013) Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studies. Clin Cancer Res19: 1244-1256

[70] ShindoS, NumazawaS, YoshidaT (2007) A physiological role of AMP-activated protein kinase in phenobarbital-mediated constitutive androstane receptor activation and CYP2B induction. Biochem J401: 735-741

[71] SidhuJS, OmiecinskiCJ (1995) cAMP-associated inhibition of phenobarbital-inducible cytochrome P450 gene expression in primary rat hepatocyte cultures. J Biol Chem270: 12762-12773

[72] SidhuJS, OmiecinskiCJ (1997) An okadaic acid-sensitive pathway involved in the phenobarbital-mediated induction of CYP2B gene expression in primary rat hepatocyte cultures. J Pharmacol Exp Ther282: 1122-1129

[73] StanleyLA, HorsburghBC, RossJ, ScheerN, WolfCR (2006) PXR and CAR: nuclear receptors which play a pivotal role in drug disposition and chemical toxicity. Drug Metab Rev38: 515-597

[74] SueyoshiT, MooreR, SugataniJ, MatsumuraY, NegishiM (2008) PPP1R16A, the membrane subunit of protein phosphatase 1beta, signals nuclear translocation of the nuclear receptor constitutive active/androstane receptor. Mol Pharmacol73: 1113-1121

[75] SugataniJ, NishitaniS, YamakawaK, YoshinariK, SueyoshiT, NegishiM, MiwaM (2005) Transcriptional regulation ofhumanUGT1A1gene expression: activated glucocorticoid receptor enhances constitutive androstane receptor/pregnane X receptor-mediated UDP-glucuronosyltransferase 1A1 regulation with glucocorticoid receptor-interacting protein 1. Mol Pharmacol67: 845-855

[76] TakizawaD, KakizakiS, HoriguchiN, YamazakiY, TojimaH, MoriM (2011) Constitutive active/androstane receptor promotes hepatocarcinogenesis in a mouse model of non-alcoholic steatohepatitis. Carcinogenesis32: 576-583

[77] ThaslerWE, DayoubR, MuhlbauerM, HellerbrandC, SingerT, GrabeA, JauchKW, SchlittHJ, WeissTS (2006) Repression of cytochrome P450 activity in human hepatocytes in vitro by a novel hepatotrophic factor, augmenter of liver regeneration. J Pharmacol Exp Ther316: 822-829

[78] TolsonAH, WangH (2010) Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR. Adv Drug Deliv Rev62: 1238-1249

[79] TzameliI, MooreDD (2001) Role reversal: new insights from new ligands for the xenobiotic receptor CAR. Trends Endocrinol Metab12: 7-10

[80] TzameliI, PissiosP, SchuetzEG, MooreDD (2000) The xenobiotic compound 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene is an agonist ligand for the nuclear receptor CAR. Mol Cell Biol20: 2951-2958

[81] WangH, TompkinsLM (2008) CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme. Curr Drug Metab9: 598-610

[82] WangH, FaucetteS, SueyoshiT, MooreR, FergusonS, NegishiM, LeCluyseEL (2003) A novel distal enhancer module regulated by pregnane X receptor/constitutive androstane receptor is essential for the maximal induction of CYP2B6 gene expression. J Biol Chem278: 14146-14152

[83] WangD, LiL, YangH, FergusonSS, BaerMR, GartenhausRB, WangH (2013) The constitutive androstane receptor is a novel therapeutic target facilitating cyclophosphamide-based treatment of hematopoietic malignancies. Blood121: 329-338

[84] WorthamM, CzerwinskiM, HeL, ParkinsonA, WanYJ (2007) Expression of constitutive androstane receptor, hepatic nuclear factor 4 alpha, and P450 oxidoreductase genes determines interindividual variability in basal expression and activity of a broad scope of xenobiotic metabolism genes in the human liver. Drug Metab Dispos35: 1700-1710

[85] XiaJ, KemperB (2007) Subcellular trafficking signals of constitutive androstane receptor: evidence for a nuclear export signal in the DNA-binding domain. Drug Metab Dispos35: 1489-1494

[86] XuRX, LambertMH, WiselyBB, WarrenEN, WeinertEE, WaittGM, WilliamsJD, CollinsJL, MooreLB, WillsonTM (2004) A structural basis for constitutive activity in the human CAR/RXRalpha heterodimer. Mol Cell16: 919-928

[87] YamamotoY, MooreR, GoldsworthyTL, NegishiM, MaronpotRR (2004) The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res64: 7197-7200

[88] YanagibaY, ItoY, KamijimaM, GonzalezFJ, NakajimaT (2009) Octachlorostyrene induces cytochrome P450, UDP-glucuronosyltransferase, and sulfotransferase via the aryl hydrocarbon receptor and constitutive androstane receptor. Toxicol Sci111: 19-26

[89] YangH, GarzelB, HeywardS, MoellerT, ShapiroP, WangH (2013) Metformin represses drug-induced expression of CYP2B6 by modulating the constitutive androstane receptor signaling. Mol Pharmacol85(2): 249-260

[90] YoshidaY, KimuraN, OdaH, KakinumaA (1996) Insulin suppresses the induction of CYP2B1 and CYP2B2 gene expression by phenobarbital in adult rat cultured hepatocytes. Biochem Biophys Res Commun229: 182-188

[91] YoshinariK, KobayashiK, MooreR, KawamotoT, NegishiM (2003) Identification of the nuclear receptor CAR:HSP90 complex in mouse liver and recruitment of protein phosphatase 2A in response to phenobarbital. FEBS Lett548: 17-20

[92] YoshinariK, YodaN, ToriyabeT, YamazoeY (2010) Constitutive androstane receptor transcriptionally activates human CYP1A1 and CYP1A2 genes through a common regulatory element in the 5’-flanking region. Biochem Pharmacol79: 261-269

[93] ZelkoI, SueyoshiT, KawamotoT, MooreR, NegishiM (2001) The peptide near the C terminus regulates receptor CAR nuclear translocation induced by xenochemicals in mouse liver. Mol Cell Biol21: 2838-2846

[94] ZhangJ, HuangW, ChuaSS, WeiP, MooreDD (2002) Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR. Science298: 422-424

RIGHTS & PERMISSIONS

2014 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.